SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Politics : The Trump Presidency -- Ignore unavailable to you. Want to Upgrade?

To: i-node who wrote (314014)12/23/2024 10:40:08 AM
From: puborectalis3 Recommendations

Recommended By
koan
rdkflorida2
Ted Beneke

  Read Replies (1) | Respond to of 361771
 
Controversial study of hydroxychloroquine for COVID-19 treatment retracted
A controversial COVID-19 treatment study that influenced early pandemic drug policy has been retracted by the International Journal of Antimicrobial Agents, more than four-and-a-half years after its publication. The paper, which promoted hydroxychloroquine (HCQ) as a potential treatment for COVID-19, marks the 28th retraction for its prominent co-author,



To: i-node who wrote (314014)12/23/2024 11:22:07 AM
From: Thomas A Watson1 Recommendation

Recommended By
longz

  Respond to of 361771
 
I have read lots of books on European history. To me America's law is the most humane evolution of English Common law. There are all manner of historical fiction covering the England of the Revolutionary war and the Napoleon war and the war of 1812. In most their is the out of wedlock woman and they all seem to end up in an alley and then dead.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News